rs587783519
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001195553.2(DCX):c.115C>T(p.Arg39*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,098,189 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001195553.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCX | ENST00000636035.2 | c.115C>T | p.Arg39* | stop_gained | Exon 2 of 7 | 2 | NM_001195553.2 | ENSP00000490614.1 | ||
DCX | ENST00000356220.8 | c.115C>T | p.Arg39* | stop_gained | Exon 3 of 8 | 5 | ENSP00000348553.4 | |||
DCX | ENST00000637453.1 | c.115C>T | p.Arg39* | stop_gained | Exon 2 of 7 | 5 | ENSP00000490357.1 | |||
DCX | ENST00000637570.1 | c.115C>T | p.Arg39* | stop_gained | Exon 2 of 7 | 5 | ENSP00000490878.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1098189Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 363587
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.115C>T (p.R39*) alteration, located in exon 2 (coding exon 1) of the DCX gene, consists of a C to T substitution at nucleotide position 115. This changes the amino acid from a arginine (R) to a stop codon at amino acid position 39. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration has been detected in multiple female patients with DCX-related lissencephaly (Des Portes, 1998; Spencer-Smith, 2009), including as a de novo event in multiple unrelated female patients with subcortical band heterotopia (Bahi-Buisson, 2013). In a yeast two-hybrid assay, the p.R39* alteration was shown to cause a complete loss of binding to neurabin II, a protein that is critical for DCX function (Tsukada, 2003). Based on the available evidence, this alteration is classified as pathogenic. -
Lissencephaly type 1 due to doublecortin gene mutation Pathogenic:1
- -
Ectopic tissue Pathogenic:1
- -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg39*) in the DCX gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DCX are known to be pathogenic (PMID: 11175293, 23365099). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with subcortical band heterotopia (PMID: 9618162). ClinVar contains an entry for this variant (Variation ID: 158425). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at